To highlight the extensive body of knowledge collected in developing the Global Vaccine Action Plan (GVAP), the journal Vaccine today released a special supplement dedicated in full to the Decade of Vaccines.

PDPs Applaud Japan’s First Public-Private Partnership to Spearhead Innovation in Global Health

A new public-private partnership of the Japanese Government, the Bill &Melinda Gates Foundation and a group of private pharmaceutical companies seeks to foster and harness Japanese innovation to address diseases that disproportionately affect low- and middle-income countries.

Huffington Post: Where Are the Scientist-Advocates and Civic-Scientists?

The flattening in support for biomedical research as well as other research fields in the United States over the last decade is having serious consequences for American science and scientists. Ultimately, we need a new generation of scientist-advocates and policy experts if we expect to reverse this trend.
When it comes to scientific research, not all schistosomes are treated equally.
On Tuesday, two of Sabin Vaccine Institute’s senior executives, Dr. Peter Hotez and Dr. Ciro de Quadros, were named among the “Top 50 Global Vaccine Influencers” by Vaccine Nation. Both Dr. Hotez and Dr. de Quadros have made significant contributions in global health throughout their careers and the countless lives they have touched stand as a testament to their vaccine advocacy and development efforts.
In this first study of its kind, Drs. Hotez and Lee measured the health and economic impact of Chagas disease and found that the total economic burden matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer. In total, the study estimates that the global economic cost of Chagas disease exceeds USD $7 billion annually.

Pages

Subscribe to RSS - Sabin Vaccine Development